SCHEMBL3349912

SCHEMBL3349912

CCCCCCCC/C=C\CCCCCCCCC(CCCN)(C(=O)[O-])[N+](C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 7/20 0.46
FAAH O00519 3/20 0.44
SOAT1 P35610 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C19 P33261 2/20 0.44
MEN1 O00255 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
KMT2A Q03164 1/20 0.44
SLC6A5 Q9Y345 2/20 0.44
KDM4E B2RXH2 2/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
APEX1 P27695 1/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455190 0.89 FABP3 (0.56) FABP3SOAT1MEN1TP53CYP3A4
SCHEMBL20853667 0.83 CES2 (0.41)
SCHEMBL5997223 0.83 TERT (0.47) FABP3FAAHCYP1A2CYP2C19KMT2A
SCHEMBL5498777 0.83 ACLY (0.55) FABP3FAAHCYP1A2CYP2C19KMT2A
SCHEMBL15065991 0.80 CES2 (0.39)
SCHEMBL10711653 0.80 CES2 (0.39)
SCHEMBL14877188 0.77 FAAH (0.41) FABP3FAAHSOAT1CYP1A2CYP2C19
SCHEMBL2542389 0.77 DNM1 (0.40) MEN1KMT2ALMNAHSD17B10
SCHEMBL7900186 0.76 CES2 (0.38)
Dectaflur SCHEMBL29126007 0.75 FABP3 (0.61) FABP3FAAHSOAT1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118356388-A Extraction method of gentian root extract, freeze-dried powder and application thereof 广州荃智美肤生物科技研究院有限公司 2024-07-19 CN claimed
US-7861782-B2 Foamed cement compositions, additives, and associated methods HALLIBURTON ENERGY SERVICES INC. (US) 2011-01-04 US claimed
CN-118356388-A Extraction method of gentian root extract, freeze-dried powder and application thereof 广州荃智美肤生物科技研究院有限公司 2024-07-19 CN disclosed
CN-118356388-A Extraction method of gentian root extract, freeze-dried powder and application thereof 广州荃智美肤生物科技研究院有限公司 2024-07-19 CN disclosed
WO-2024149652-A1 BLENDS OF AMIDOPROPYL BETAINES DERIVED FROM FATTY ACID MIXTURES COMPRISING UNSATURATED FATTY ACIDS AND ALK(EN)YL (POLY)GLYCOSIDES BASF SE (DE) 2024-07-18 WO disclosed
WO-2024149654-A1 USE OF UNSATURATED FATTY ACID AMIDOPROPYL BETAINES AS THICKENERS BASF SE (DE) 2024-07-18 WO disclosed
US-20240191127-A1 VISCOELASTIC SURFACTANT FORMULATIONS AND USE IN SUBTERRANEAN FORMATIONS Energy Solutions (US) LLC (US) 2024-06-13 US disclosed
CN-118159632-A Perfume and perfume mixture 西姆莱斯股份公司 2024-06-07 CN disclosed
US-20240182778-A1 VISCOELASTIC SURFACTANT FORMULATIONS AND USE IN SUBTERRANEAN FORMATIONS Energy Solutions (US) LLC (US) 2024-06-06 US disclosed
CN-118139956-A Boron-free water-based lubricant for plastic working 汉高股份有限及两合公司 2024-06-04 CN disclosed
WO-2024112838-A1 VISCOELASTIC SURFACTANT FORMULATIONS AND USE IN SUBTERRANEAN FORMATIONS Energy Solutions (US) LLC (US) 2024-05-30 WO disclosed
CN-116583261-A Method for combating microorganisms using menthol derivatives 西姆莱斯股份公司 2023-08-11 CN disclosed
CN-116546961-A Composition for product protection comprising (bio) -alkanediol and antimicrobial agent 西姆莱斯股份公司 2023-08-04 CN disclosed
CN-116490160-A A mixture containing 1, 2-alkanediol 西姆莱斯股份公司 2023-07-25 CN disclosed
CN-113543637-B Antimicrobial mixture 西姆莱斯股份公司 2023-07-14 CN disclosed
CN-114402005-A Composition comprising an alkali-swellable copolymer 罗门哈斯公司 2022-04-26 CN disclosed
US-7861782-B2 Foamed cement compositions, additives, and associated methods HALLIBURTON ENERGY SERVICES INC. (US) 2011-01-04 US disclosed
US-20100025040-A1 Foamed Cement Compositions, Additives, and Associated Methods HALLIBURTON ENERGY SERVICES, INC. 2010-02-04 US disclosed
US-20020034480-A1 Make-up compositions comprising a binder phase, and make-up methods L'OREAL, S.A. (FR) 2002-03-21 US disclosed
US-4647480-A Use of additive in aqueous cure of autodeposited coatings AMCHEM PRODUCTS, INC. (US) 1987-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034480-A1 Make-up compositions comprising a binder phase, and make-up methods TTR, GRN, MB FABP3 339/4885FAAH 4432/4885SOAT1 4073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.